Eli Lilly's stock has been receiving many upgrades after posting strong quarterly results in February.

Eli Lilly's stock is down this year, and its high valuation may be a big reason why.

Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.

Eli Lilly's stock price is based on growth rates that might fall short.

Eli Lilly (NYSE:LLY) stock is down 5% in Tuesday afternoon trading, with shares falling to $937 from a prior close of $989.12 ...

Eli Lilly (LLY) stock declined after HSBC downgrade to Reduce with $850 price target, citing obesity drug market risks and ...

Eli Lilly (LLY) stock drops as HSBC downgrades the company warning that weight-loss drugmaker could be “priced to perfection.

Eli Lilly (LLY) is quietly emerging as one of the most talked-about stock split candidates for 2026, and that's not just because of headlines. Analysts point to its elevated share price as a barrier ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 6.3% in the afternoon session after investment bank HSBC ...

Eli Lilly (LLY) stock is lower today, after HSBC downgraded it to "reduce" from "hold," citing an inflated obesity drug market ...

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust business that is delivering excellent results and ...

Eli Lilly (NYSE: LLY) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in market value. The company briefly touched that level in November but has since ...